Gastroesophageal Reflux
Conditions
Brief summary
After vonoprazan (20mg/day) or esomeprazole (20mg/day) for 4weeks is prescribed for patients with erosive esophagitis diagnosed by esophagogastroduodenoscopy, the number of patients who will visit our outpatient clinic again due to some reasons without any appointments is compared with vonoprazan group and esomeprazole.
Detailed description
1. Patients who have erosive esophagitis diagnosed by esophagogastroduodenoscopy is enrolled. 2. Vonoprazan (20mg/day) or esomeprazole (20mg/day) is prescribed for 4weeks the patients randomly without next appointments. 3. Some patients may visit our outpatient clinic again due to some reasons without any appointments. 4. The number of the patients who revisit our outpatient clinic again is compared with vonoprazan group and esomeprazole.
Interventions
Vonoprazan (20mg/day) is prescribed for 4 weeks.
esomeprazole (20mg/day)
Sponsors
Study design
Eligibility
Inclusion criteria
* outpatients belonging to American Society of Anesthesiologists class I or II * patients have erosive esophagitis diagnosed by esophagogastroduodenoscopy shortly before the prescription
Exclusion criteria
* other acid blockers are taken
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The number of patients who revisit our outpatient clinic after the prescription without any appointments | 3 months | The need to revisit our outpatient clinic again without any appointments may show the patients' satisfaction or dissatisfaction after the prescription of vonoprazan or esomeprazole. The difference in the number between the two groups may show the difference in the effectiveness between the two medicines. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change of the main symptom with patients after/before medication when the patients revisit again | 3 months | The ratio of the degree of the main symptom after/before taking the medicine Good 0%- Bad 100% |
Other
| Measure | Time frame | Description |
|---|---|---|
| Questionnaire on satisfaction with taking the medicine at revisiting | 3months | The patient's satisfaction is assessed using visual analogue scale (Exellent 100% to very bad 0%). |
Countries
Japan